Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted Analysis
Clinical trial NCT07549269 · COMPLETED
Trial details
- NCT number
- NCT07549269
- Sponsor
- Sichuan University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-12-01
- Primary completion
- 2024-12-01
- Enrollment
- 387
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.